1Rock G, Berger R, Lange J, et al. A novel, automated method of temperature cycling to produce cryoprecipitate [ J ]. Transfusion, 2001,41 (2) :232-235
2Homsey VS, Young DA, Docherty A, et al. Cryoprecipitate prepared from plasma treated with methylene blue plus light:increasing the fibfiuogen concentration [ J ]. Transfus Med, 2004, 14 (5) :369-374
3Pesquera-Lepatan LM, Hemandez FG, Lira RD, et al. Thawed eryopreeipitate stored for 6h at room temperature: a potential alternative to factor Ⅷ concentrate for continuous infusion [ J]. Haemophilia,2004,10(6) :684-688.
4Burnouf T, Goubran HA, Radosevich M, et al. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres usirig a disposable bag system [ J]. Vox Sang,2006,91 ( 1 ) :56-62
5Bumouf T, Goubran HA, Radosevich M, et al. Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems [ J ]. Transfus Clin Biol,2008,15 ( 3 ) : 129-134
6Burnouf T, Caron C, Radosevich M, et al. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems[ J]. Haemophilia,2008,14 (5) :956-962.
7Yousef H, Neurath D, Freedman M, et al. Cryopreeipitate production:the use of additives to enhance the yield [ J ]. Clin Lab Haematol, 2006,28 ( 4 ) : 237 -240
8Rudelstorfer B, Loidl K, Heider R, et al. Wound closure of the fallopian tube with fibrin glue : endoscopic organ preserving therapy of extrauterine pregnancy [ J ]. Gynakol Geburtshilfliche Rundsch, 1997,37(2) :62-67
9Mathews V, Srivastava A, Nair SC, et al. Haemostasis with cryoprecipitate in patients undergoing surgery for severe yon Willebrand disease [J]. Natl Med J India,2000,13(4) :188-190
10Farrugia A. Evolving perspectives in product safety for haemophilia [ J ]. Haemophilia, 2002,8 ( 3 ) :236-243
